Benitec Biopharma
BNTC
#8208
Rank
C$0.48 B
Marketcap
C$13.94
Share price
3.46%
Change (1 day)
-23.02%
Change (1 year)

Operating Margin for Benitec Biopharma (BNTC)

Operating Margin as of November 2026 (TTM): -26,082.70%

According to Benitec Biopharma 's latest financial reports and stock price the company's current Operating Margin is -26,082.70%. At the end of 2022 the company had an Operating Margin of -24,942.47%.

Operating Margin history for Benitec Biopharma from 2015 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2022-24,942.47%6.01%
2021-23,528.81%175.84%
2020-8,529.90%-33767.47%
201925.34%-101.35%
2018-1,877.42%93.35%
2017-970.99%-81.82%
2016-5,340.09%401.58%
2015-1,064.66%0%
2014-1,064.66%-15.03%
2013-1,253.01%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Nymox Pharmaceutical
NYMX
-234,760.00% 800.06% Bahamas
NRC Health
NRC
12.98%-100.05%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.